Royal London Asset Management LTD Exact Sciences Corp Transaction History

Royal London Asset Management LTD

$39.4 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$41.33 - $74.26 $95,182 - $171,020	2,303 Added 3.28%	72,611 $3.07 Million
Q1 2024 May 14, 2024	SELL	$56.27 - $73.77 $6,189 - $8,114	-110 Reduced 0.16%	70,308 $4.86 Million
Q4 2023 Feb 13, 2024	BUY	$59.06 - $75.72 $120,482 - $154,468	2,040 Added 2.98%	70,418 $5.21 Million
Q3 2023 Nov 14, 2023	BUY	$65.94 - $99.04 $262,639 - $394,476	3,983 Added 6.19%	68,378 $4.66 Million
Q2 2023 Aug 11, 2023	BUY	$62.68 - $95.05 $177,133 - $268,611	2,826 Added 4.59%	64,395 $6.05 Million
Q1 2023 May 15, 2023	BUY	$47.19 - $70.77 $39,026 - $58,526	827 Added 1.36%	61,569 $4.17 Million
Q4 2022 Feb 09, 2023	BUY	$30.35 - $53.15 $89,532 - $156,792	2,950 Added 5.1%	60,742 $3.01 Million
Q3 2022 Nov 14, 2022	SELL	$31.97 - $49.37 $137,247 - $211,945	-4,293 Reduced 6.91%	57,792 $1.88 Million
Q2 2022 Aug 12, 2022	BUY	$35.61 - $76.23 $41,022 - $87,816	1,152 Added 1.89%	62,085 $2.45 Million
Q1 2022 May 13, 2022	BUY	$57.56 - $82.54 $163,009 - $233,753	2,832 Added 4.87%	60,933 $4.26 Million
Q4 2021 Oct 18, 2022	SELL	$72.5 - $100.68 $80,402 - $111,654	-1,109 Reduced 1.87%	58,101 $4.52 Million
Q4 2021 Jan 18, 2022	SELL	$72.5 - $100.68 $80,402 - $111,654	-1,109 Reduced 1.87%	58,101 $4.52 Million
Q3 2021 Oct 18, 2022	SELL	$90.24 - $124.05 $288,948 - $397,208	-3,202 Reduced 5.13%	59,210 $5.65 Million
Q3 2021 Nov 02, 2021	SELL	$90.24 - $124.05 $288,948 - $397,208	-3,202 Reduced 5.13%	59,210 $5.65 Million
Q2 2021 Oct 18, 2022	BUY	$93.66 - $139.27 $30,626 - $45,541	327 Added 0.53%	62,412 $7.75 Million
Q2 2021 Jul 14, 2021	BUY	$93.66 - $139.27 $743,847 - $1.11 Million	7,942 Added 14.58%	62,412 $7.75 Million
Q1 2021 Oct 17, 2022	SELL	$116.57 - $155.01 $887,680 - $1.18 Million	-7,615 Reduced 12.27%	54,470 $7.18 Million
Q1 2021 Apr 13, 2021	BUY	$116.57 - $155.01 $127,644 - $169,735	1,095 Added 2.05%	54,470 $7.18 Million
Q4 2020 Jan 29, 2021	SELL	$99.61 - $142.12 $112,957 - $161,164	-1,134 Reduced 2.08%	53,375 $7.08 Million
Q3 2020 Nov 04, 2020	BUY	$72.92 - $102.01 $38,283 - $53,555	525 Added 0.97%	54,509 $5.56 Million
Q4 2019 Feb 05, 2020	BUY	$77.66 - $99.74 $644,422 - $827,642	8,298 Added 18.16%	53,984 $4.96 Million
Q3 2019 Nov 12, 2019	BUY	$90.37 - $122.49 $4.13 Million - $5.6 Million	45,686 New	45,686 $4.13 Million

Others Institutions Holding EXAS

# of Institutions

673

Shares Held

162M

Call Options Held

2.58M

Put Options Held

2.19M

Vanguard Group Inc Valley Forge, PA

17.8M
Shares

$1.03 Billion
0.02% of portfolio
Capital World Investors Los Angeles, CA

15.8M
Shares

$921 Million
0.17% of portfolio
Wellington Management Group LLP Boston, MA

14.3M
Shares

$833 Million
0.18% of portfolio
Black Rock Inc. New York, NY

12.1M
Shares

$701 Million
0.01% of portfolio
State Street Corp Boston, MA

6.68M
Shares

$388 Million
0.02% of portfolio

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.3B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal London Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Royal London Asset Management LTD with notifications on news.

Account